Clinical Trial Update: Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial update of cemiplimab in patients with cutaneous squamous cell carcinoma (Stage II to IV) has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• Cemiplimab (Libtayo) (cemiplimab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Cutaneous Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2023-02-08